• Careers
  • Contact Us
  • About Us
    • Leadership
    • Careers
  • Research & Development
    • Our Pipeline
    • Publications
    • Collaborations
    • Expanded Access
  • Investors
    • Press Releases
    • Presentations
    • Governance
    • Financials & Fillings
    • Stock Information
    • Investors FAQs
    • Request Information
  • Contact Us

Chimerix Licenses CX-01 for First-Line Treatment of Acute Myeloid Leukemia

Learn More

Banner 1

Accelerating advances of innovative medicines that make a meaningful impact in the lives of patients with cancer and other serious diseases.

News

    • Chimerix Announces Second Quarter 2019 Financial Results and Operational Update
      Aug 08 2019
    • Chimerix Announces Exclusive Worldwide License of Phase 3 Ready CX-01 for Development in Acute Myeloid Leukemia
      Jul 31 2019
    Older posts
view all
  • Privacy Policy
  • Terms & Conditions of Use
  • Forward-Looking Statements
  • Community Guidelines
  • References
  • Contact Us

© 2018 Chimerix. All rights reserved.

About Us
  • Leadership
  • Careers
Research & Development
  • Publications
  • Collaborations
  • Expanded Access
Investors
  • Press Releases
  • Presentations
  • Governance
  • Financials & Filings
  • Stock Information
  • Investor FAQs
  • Request Information
Contact Us
  • Privacy Policy
  • Terms & Conditions of Use
  • Forward-Looking Statements
  • Community Guidelines
  • References
  • Contact Us

© 2018 Chimerix. All rights reserved.